RPL7P51

Across TCGA pan-cancer cohorts, RPL7P51 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RPL7P51 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RPL7P51 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPL7P51 expression acts as an unfavorable survival marker, although some lineages such as HNSC and ESCA show a favorable association.

HNSC, ESCA, and BRCA are the cancer types where RPL7P51 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Quartile	All	0.556	0.322	.003	90	view →
ESCA	DFS	Tertile	All	0.489	0.224	.001	83	view →
BRCA	DFS	Quartile	All	0.980	0.939	<.001	66	view →
THCA	OS	Tertile	II,III,IV	0.889	0.982	.005	54	view →
UCS	OS	Quartile	III,IV	0.275	0.684	.002	44	view →
KICH	DFS	Tertile	III,IV	0.025	0.773	<.001	39	view →
LUAD	DFS	Quartile	All	0.753	0.627	.012	22	view →
UCEC	OS	Tertile	III,IV	0.741	0.852	.037	22	view →
DLBC	DFS	Quartile	II,III,IV	0.203	0.951	.003	18	view →
UVM	OS	Quartile	All	1.000	0.415	.031	16	view →
LGG	DFS	Tertile	All	0.287	0.439	.008	13	view →
LUSC	OS	Tertile	III,IV	0.517	0.743	.005	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RPL7P51–HNSC (OS)

Open the HNSC breakdown →